(Press-News.org) Lymph nodes are one of the body’s first lines of defense against disease. Immune cells are dispatched from these biological police stations to fight off intruders. But somehow, lymph nodes are also the first stop for most metastatic cancers.
“It’s paradoxical,” Cold Spring Harbor Laboratory (CSHL) Assistant Professor Semir Beyaz says. “The cancer goes right in, but the immune cells aren’t doing anything. It’s important to understand what’s going on because this is how cancer takes the whole body hostage.”
Beyaz joined with collaborators from Massachusetts General Hospital to investigate. They found that breast cancer cells trick the immune system with help from a molecule called MHC-II. Future therapeutics targeting this molecule may help slow the cancer’s spread and improve patient outcomes.
“MHC-II acts like breast cancer’s passport,” Beyaz says. “It convinces the lymph node to let the cancer in and protect it. From there, it’s mayhem.”
In other places, like the intestine, MHC-II helps destroy abnormal cells before they become a problem. But breast cancer’s version of MHC-II doesn’t carry the red flags immune cells recognize. So, the lymph node treats it like a false alarm. Beyaz explains:
“Cancer hijacks the lymph node—the police station. The detectives just say, ‘Welcome. Here’s a comfy couch. Here’s a coffee.’ Cancer bribes the neighboring cells. Then it grows. This is what MHC-II is doing in lymph node metastasis.”
The team found that, in mice, higher levels of MHC-II on a subset of cancer cells led to greater immune suppression in lymph nodes. This caused worse metastasis and shorter survival. When they switched off MHC-II production in cancer cells, lymph nodes awoke to the threat. As a result, the cancer couldn’t spread as fast, and the mice lived longer.
“If you get rid of MHC-II in cancer cells, you curb the invasion,” Beyaz explains. “The lymph nodes stop suppressing immune response and reduce cancer’s colonizing abilities.”
Beyaz now hopes to reveal exactly how cancer adapts and spreads. Understanding these mechanisms could bring us closer to new metastasis-blocking therapeutics. But, he cautions, the effectiveness of any potential drug will depend on where cancer first develops.
“For example, in the gut, we see the opposite of what’s happening in breast cancer,” Beyaz explains. “There are context-specific rules, and this tells us there is no one cure-all.”
Over 300,000 people in the U.S. will be diagnosed with breast cancer this year alone. While a long journey lies ahead, Beyaz thinks this research may someday have clinical implications that lead to better therapies and improve patients’ lives.
END
Metastatic breast cancer’s Trojan horse
2023-07-26
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Collaborating with a university on a new product? Let your customers know!
2023-07-26
Researchers from WU Vienna University of Economics and Business, University of Bonn, and FAU Erlangen-Nürnberg published a new Journal of Marketing article that examines how consumers respond to new products co-developed with universities and the unique marketing opportunities for these products.
Firms often collaborate with universities to access novel scientific knowledge and technological expertise with an aim to develop superior new products. For example, Italian start-up Angles90 co-developed the first dynamic training grips with the faculty of Strength Training Ergonomics at the Technical University of ...
Viral TikTok health videos tend to cover three topics, rely on influencers
2023-07-26
PULLMAN, Wash. –Sexual health, diet and exercise are the three topics that steal the show when it comes to popular health-related videos on TikTok. Unfortunately, there’s little else in terms of engaging health-related content on the video sharing platform, a Washington State University study found.
The social media platform’s mostly young audience also seems to prefer health-related videos featuring popular influencers’ role model appeals, such as their diet or exercise routine, rather than expert medical advice, ...
Octapharma's prothrombin complex concentrate, Balfaxar®, receives FDA approval for warfarin reversal in urgent surgery & invasive procedures
2023-07-26
PARAMUS, N.J., July 26, 2023 – Octapharma USA today announced that Balfaxar® (prothrombin complex concentrate, human-lans; marketed in Europe and Canada as octaplex®) has received U.S. Food and Drug Administration (FDA) approval for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with need for urgent surgery or invasive procedures.
Balfaxar® helps restore blood coagulation by replenishing the levels of clotting factors that are deficient due to warfarin therapy. Balfaxar® ...
MD Anderson and Nexo Therapeutics announce strategic research collaboration to advance new therapies against intractable targets
2023-07-26
HOUSTON, GOLDEN, Colo. and WATERTOWN, Mass. ― The University of Texas MD Anderson Cancer Center and Nexo Therapeutics today announced a multi-year strategic collaboration that aligns the innovative technology and capabilities of each organization at the earliest stages of drug discovery and development to rapidly advance impactful new cancer therapies against previously undruggable targets.
The agreement brings together Nexo’s unique drug discovery platform, which combines innovative covalent chemistry and chemical biology, with the translational research and drug development expertise ...
Western science catches up with First Nations’ medicinal use of ant honey
2023-07-26
Scientists have discovered the honey produced by Australian ants possesses unique anti-microbial activity against bacteria and fungi that could make the liquid useful medicinally.
The research, published today in PeerJ, was led by Andrew Dong and Dr Kenya Fernandes from the University of Sydney’s Carter Lab, which is led by Professor Dee Carter from the School of Life and Environmental Sciences and Sydney Institute for Infectious Diseases.
The team studied the Australian honeypot ant, Camponotus inflatus, which is found throughout desert areas mainly in Western Australia and the Northern Territory.
Among ...
Children’s Hospital Colorado launches state’s first pediatric precision medicine institute
2023-07-26
Aurora, Colo. (July 26, 2023) – Children’s Hospital Colorado (Children’s Colorado) today announced the launch of the Precision Medicine Institute, which will allow experts to more efficiently integrate precision medicine into care provided to patients throughout the hospital. The Precision Medicine Institute uses innovative technology to integrate big data, including genomic data, into each individual patient's care plan to determine the best treatment for each patient.
Precision medicine, also known as personalized medicine or genomic medicine, uses the most up-to-date technology ...
Asian adults in U.S. less likely to survive cardiac arrest despite bystander CPR equal to white adults
2023-07-26
Research Highlights:
Despite similar rates of bystander CPR after an out-of-hospital cardiac arrest, Asian adults in the U.S. were 8% less likely to survive to hospital discharge and 15% less likely to have favorable neurological outcomes compared to white adults, according to an analysis of nearly 279,000 out-of-hospital cardiac arrests.
The study is believed to be the first research comparing bystander CPR and survival rates between Asian and white adults in the U.S. after cardiac arrest.
Embargoed until 4 a.m. CT/5 a.m. ET Wednesday, July 26, 2023
DALLAS, July 26, 2023 — Despite similar rates of bystander CPR after an out-of-hospital cardiac arrest, Asian ...
Arctic terns may navigate climate dangers
2023-07-26
Arctic terns – which fly on the longest migrations of any animal on Earth – may be able to navigate the dangers posed by climate change, new research suggests.
The birds live in near-perpetual daylight, breeding in the north of our planet and flying to Antarctica for the Southern Hemisphere summer, covering enough distance in their lifetime to travel to the moon three times.
The new study, led by the University of Exeter and the Met Office, examined the likely impacts of climate change on arctic terns outside of ...
Bromide ions cause ripples in semiclathrate hydrates
2023-07-26
Osaka, Japan – The way that water molecules behave in proton conducting materials is very important for understanding—and making the most of—their properties. This means being able to look at very rapid snapshots to catch changes in the water motion. Researchers from Osaka University have taken a close look at semiclathrate hydrate crystals using quasi-elastic neutron scattering (QENS). Their findings are published in Applied Physics Letters.
Semiclathrate hydrates have water molecule frameworks that house other molecules or ions as ‘guests’ in their structures. The overall properties of the framework can therefore be controlled and tailored to particular ...
Intervalence charge transfer of Cr³⁺-Cr³⁺ aggregation for NIR-Ⅱ luminescence
2023-07-26
The near-infrared (NIR) spectrum contains characteristic vibrational absorption bands of numerous organic functional groups. NIR phosphor-converted light-emitting diodes (pc-LEDs) have gathered increasing interests in fields including non-destructive testing and night vision. In 2016, Osram reported the first NIR pc-LED, SFH4735, while with low output power (16 mW @ 350 mA) and limited wavelengths. Furthermore, luminescent contrast agents operating within the second biological imaging window (1000-1800 nm) exhibit lower tissue absorption and scattering coefficients in contrast to the traditional first window (750-950 nm), thereby ...